Remedi

Remedi is a regenerative medicine brand and technology platform specializing in autologous micrografting for the treatment of musculoskeletal and dermatological conditions. Formed through the merger of Regenera Activa Worldwide and Rigenera HBW, the company utilizes its patented Rigenera technology to perform mechanical disaggregation of a small tissue biopsy (such as skin or cartilage) into a suspension of progenitor cells, growth factors, and extracellular matrix components. This autologous solution, often referred to as the AMT Triad, is re-injected into the patient to stimulate tissue repair and restore cellular communication. The therapy is primarily indicated for osteoarthritis, where it aims to halt joint degeneration and alleviate pain, as well as for androgenetic alopecia (hair regeneration) and complex wound healing. It is designed as a minimally invasive, single-session procedure that leverages the body's innate healing capacity without the need for extensive ex vivo cell manipulation or culture.

Brand names

RemediRigeneraRegenera Activa

Other names

Autologous Micrografting TechnologyAMT Triad